By Counterforce Health Team in Elaprase (idursulfase) —

How to Get Elaprase (Idursulfase) Covered by Aetna (CVS Health) in Illinois: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Elaprase (Idursulfase) Covered by Aetna (CVS Health) in Illinois

Aetna (CVS Health) requires prior authorization for Elaprase (idursulfase) with confirmed Hunter syndrome diagnosis via enzyme assay or genetic testing. Submit Aetna's Elaprase Precertification Form (GR-69518) through your metabolic specialist with weight-based dosing calculations. Illinois provides strong appeal protections: internal appeals must be decided within 15 business days, with external review available through the Illinois Department of Insurance if denied. Starting January 1, 2026, Illinois bans step therapy requirements entirely, eliminating trial-and-fail mandates for covered drugs.

Table of Contents

Why Illinois State Rules Matter

Illinois has some of the strongest patient protection laws in the country, which directly impact how Aetna (CVS Health) handles specialty drug approvals. The state's regulations create binding timelines that insurers must follow, regardless of their internal policies.

Key Illinois Protections:

  • Step therapy ban (effective January 1, 2026): Illinois law 215 ILCS 134/87 prohibits insurers from requiring patients to try cheaper alternatives before covering prescribed treatments
  • Strict appeal deadlines: Internal appeals must be decided within 15 business days for non-urgent cases, 24 hours for expedited
  • External review rights: Independent physician review available through the Illinois Department of Insurance with binding decisions
  • Consumer assistance: Office of Consumer Health Insurance (OCHI) provides free help at (877) 527-9431

These protections apply to all Illinois-issued health plans, including employer-sponsored coverage through Aetna (CVS Health).

Coverage at a Glance

Requirement What It Means Where to Find It Source
Prior Authorization Required for all Elaprase prescriptions Aetna Precertification Lists ✓
Formulary Status Covered on specialty tier with PA 2026 Medical Drug List ✓
Step Therapy Banned in Illinois (Jan 1, 2026) Illinois Step Therapy Ban ✓
Specialty Pharmacy CVS Specialty required Aetna Specialty Drug List ✓
Site of Care Hospital outpatient preferred first 45 days Aetna Site of Care Policy ✓
Appeals Deadline 180 days from denial date Aetna member materials ✓

Step-by-Step: Fastest Path to Approval

1. Gather Required Documentation (Patient/Caregiver)

  • Insurance card and member ID
  • Complete Hunter syndrome diagnosis records (enzyme assay or genetic testing)
  • Current weight and previous Elaprase dosing history (if applicable)
  • Prior treatment records showing medical necessity

2. Schedule with Metabolic Specialist (Within 1 week) Your prescriber must be a specialist in metabolic or lysosomal storage disorders. General pediatricians or internists may face additional scrutiny.

3. Submit Prior Authorization (Prescriber) Complete Aetna's Elaprase Precertification Form (GR-69518) via:

4. Include Weight-Based Dosing Calculations Document exact dosing at 0.5 mg/kg weekly with vial requirements and waste calculations.

5. Specify Infusion Site and Monitoring Plan Include safety protocols, especially for first 45 days when hospital outpatient setting is preferred.

6. Track Decision Timeline

  • Standard: 7-45 days (submit ≥14 days before treatment)
  • Expedited: ≤72 hours for urgent cases
  • Follow up via Availity or call member services

7. If Denied, Appeal Immediately Use Illinois's strong appeal protections (detailed below) within 180 days of denial notice.

Illinois Prior Authorization Standards

Illinois requires insurers to follow specific timelines that often move faster than Aetna's standard processes:

Turnaround Requirements

  • Standard requests: 15 business days after receiving complete information
  • Expedited requests: 24 hours when delay would significantly increase health risk
  • Missing information: Insurer must request within 3 business days of submission
Tip: For Elaprase, emphasize any respiratory complications, airway issues, or cardiac involvement to qualify for expedited review under Illinois law.

Documentation Standards

Illinois law requires insurers to specify exactly what clinical information they need. Aetna cannot request additional documents beyond what's listed in their published prior authorization criteria.

Step Therapy Protections in Illinois

Major Change for 2026: Illinois completely bans step therapy requirements for prescription drugs under 215 ILCS 134/87. This means:

  • No trial-and-fail requirements: Aetna cannot require you to try cheaper alternatives first
  • Immediate access: If Elaprase is on formulary, step therapy cannot be a barrier
  • Applies broadly: Covers all Illinois-issued commercial plans

Before January 1, 2026

If you're seeking coverage before the ban takes effect, Illinois still provides medical exception pathways:

  • Document any contraindications to alternative treatments
  • Emphasize Hunter syndrome's progressive nature requiring immediate intervention
  • Note that no FDA-approved alternatives exist for MPS II enzyme replacement

Counterforce Health helps patients and clinicians navigate these complex step therapy requirements by automatically generating evidence-backed appeals that cite Illinois-specific protections and medical necessity criteria.

Continuity of Care Rights

Illinois provides strong continuity protections when transitioning between plans or during coverage changes:

Ongoing Therapy Protection

  • 30-day bridge coverage: Required when switching from another insurer to Aetna
  • No interruption during appeals: Coverage must continue during internal appeal process
  • Dosing adjustments: Weight-based changes don't require new PA if within approved parameters

Grace Periods

Illinois requires a minimum 30-day supply during:

  • Plan transitions
  • Formulary changes
  • Provider network changes affecting infusion sites

External Review and Complaints Process

If Aetna denies your internal appeal, Illinois provides independent external review through licensed physicians:

External Review Eligibility

  • Internal appeal denied or delayed beyond 30 days
  • File within 4 months of final denial notice (shorter than many states)
  • Available for medical necessity and experimental/investigational denials

How to File External Review

  1. Download forms: Illinois External Review Form
  2. Submit to: Illinois Department of Insurance online or by mail
  3. Include: Denial letters, medical records, prescriber attestation
  4. Timeline: Decision within 45 days (5 business days for expedited)
Note: In 2024, Illinois external reviews overturned 627 adverse determinations in favor of consumers, with a success rate of approximately 46%.

Consumer Assistance Resources

  • OCHI Hotline: (877) 527-9431 for direct assistance with appeals
  • Illinois Attorney General Health Care Helpline: (877) 305-5145
  • Online complaint filing: Available through the Illinois Department of Insurance website

Common Denial Reasons and Fixes

Denial Reason How to Overturn Required Documentation
Missing enzymatic confirmation Submit enzyme assay results Lab report showing iduronate-2-sulfatase deficiency
Lack of genetic testing Provide molecular analysis IDS gene variant confirmation
Prescriber not specialist Change to metabolic specialist Board certification documentation
Weight-based dosing unclear Recalculate and document Current weight, 0.5 mg/kg calculation, vial needs
Missing infusion monitoring plan Submit safety protocols Site of care details, reaction management plan
"Experimental" designation Cite FDA approval FDA label for Hunter syndrome

Appeals Playbook for Aetna (CVS Health) in Illinois

Level 1: Internal Appeal

  • Who can file: Patient, prescriber, or authorized representative
  • Deadline: 180 days from denial date
  • How to submit: Aetna member portal or call member services
  • Timeline: 15 business days (Illinois law) vs. Aetna's standard 30 days
  • Required documents: Original denial letter, medical records, prescriber letter

Level 2: External Review (Illinois DOI)

  • Eligibility: After internal appeal denial or 30-day delay
  • Deadline: 4 months from final adverse determination
  • Cost: Free to consumers (insurers pay review fees)
  • Decision: Binding on Aetna if overturned
  • Timeline: 45 days standard, 72 hours expedited

Expedited Appeals

Available when delay would "significantly increase the risk to the patient's health." For Elaprase, this includes:

  • Progressive respiratory decline
  • Severe joint contractures affecting mobility
  • Cardiac complications from Hunter syndrome

When to Escalate

Contact Illinois regulators if Aetna:

  • Misses appeal deadlines (15 business days internal, 24 hours expedited)
  • Refuses to provide required appeal forms
  • Denies peer-to-peer review requests
  • Fails to honor external review decisions

Illinois Department of Insurance

  • Consumer Hotline: (877) 527-9431
  • Online Complaints: idoi.illinois.gov
  • Mailing Address: Illinois Department of Insurance, 320 West Washington Street, Springfield, IL 62767

When filing complaints, include:

  • All denial letters and correspondence
  • Appeal submissions and responses
  • Timeline documentation showing missed deadlines
  • Impact statement describing treatment delays

FAQ

How long does Aetna (CVS Health) prior authorization take for Elaprase in Illinois? Standard decisions take 7-45 days, but Illinois law requires internal appeals within 15 business days. Submit at least 14 days before planned treatment start.

What if Elaprase is non-formulary on my Aetna plan? Request a formulary exception through your prescriber. Emphasize that no FDA-approved alternatives exist for Hunter syndrome enzyme replacement therapy.

Can I request an expedited appeal in Illinois? Yes, if treatment delay would significantly increase health risks. Document respiratory, cardiac, or mobility complications to qualify for 24-hour expedited review.

Does step therapy apply to Elaprase in Illinois? Starting January 1, 2026, Illinois bans step therapy entirely. Before then, medical exceptions are available since no alternatives exist for MPS II.

What happens if CVS Specialty can't provide Elaprase? Aetna may approve alternative specialty pharmacies for clinical reasons. Document any access issues with CVS Specialty in your appeal.

How much does Elaprase cost with Aetna coverage? Costs vary by plan, but specialty tier copays typically range from $100-500 per month. Check with member services for your specific benefits.

Can I get help with the appeals process? Yes, Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals for complex specialty medications like Elaprase. The Illinois OCHI hotline (877) 527-9431 also provides free consumer assistance.

What if my employer plan is self-funded? Self-funded ERISA plans may not be subject to all Illinois state laws, but many adopt similar timelines voluntarily. Check your Summary Plan Description for specific appeal procedures.

This article provides educational information about insurance coverage and appeals processes. It is not medical advice. Always consult with your healthcare provider about treatment decisions and work with qualified specialists familiar with Hunter syndrome management.

Sources and Further Reading

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.